TSMC to raise chip manufacturing prices by up to 10% in 2027: Nikkei
Seeking Alpha ·
Taiwan Semiconductor Manufacturing (TSMC) plans to raise prices for both advanced and mature chip manufacturing services by as much as 10% in 2027, citing higher costs for materials, production equipment, and the construction of new overseas fabrication plants, Nikkei Asia
AI 시장 분석
TSMC has announced plans to raise prices for both advanced and mature semiconductor manufacturing by up to 10% starting in 2027. This decision reflects the increasing burden of rising raw material costs and the expenses associated with constructing new overseas plants. This price hike is expected to shift the cost structure across the global semiconductor supply chain, directly impacting the profitability of related companies.
상승 영향
- Semiconductors — TSMC's price increases may lead to a broader rise in foundry industry pricing, potentially boosting profitability. Given its unrivaled technical expertise, TSMC is well-positioned to pass on costs, supporting long-term earnings growth.
하락 영향
- IT Hardware — Rising semiconductor manufacturing costs squeeze margins for makers of smartphones and PCs. If component price hikes are passed to end consumers, there is a risk of a slowdown in demand.
DYAX 전담 분석
The move underscores the pressure TSMC faces in balancing aggressive global expansion with inflationary costs. By leveraging its dominant market position, TSMC aims to pass on capital expenditures to clients. While this solidifies TSMC's margins, it creates a challenging environment for downstream tech firms that rely on its foundry services.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 54% · Bearish (Short) 46%
463 participants
Related News
- Disney parts ways with some familiar faces at ESPN
- 3M forecasts >3.5% organic growth and $4.7B-$4.9B free cash flow in 2026 as it scales expanded beam optics
- GM targets $14B-$16B 2026 EBIT adjusted while forecasting 1M new subscriptions and ~160,000 incremental Super Cruise units
- Agios pares loss after abandoning sickle cell asset tebapivat
- Forget ETHA. iShares’ Other Ether Fund Is Nearly Identical, Except It Pays You
- Update: Equity Markets Rise Intraday in Tech-Led Advance
